| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.38B | 16.55B | 8.64B | 3.91B | 1.33B | 376.03M |
| Gross Profit | 9.43B | 12.02B | 6.59B | 3.11B | 1.03B | 259.18M |
| EBITDA | 4.70B | 8.46B | 4.51B | 2.10B | 563.14M | 6.70M |
| Net Income | 3.20B | 5.79B | 2.65B | 1.33B | 368.16M | 4.25M |
Balance Sheet | ||||||
| Total Assets | 8.49B | 12.00B | 8.33B | 4.23B | 1.35B | 617.87M |
| Cash, Cash Equivalents and Short-Term Investments | 4.95B | 10.17B | 7.43B | 3.98B | 1.18B | 555.97M |
| Total Debt | 34.19M | 58.76M | 101.71M | 136.30M | 150.06M | 145.00M |
| Total Liabilities | 1.40B | 2.98B | 2.73B | 1.30B | 575.81M | 208.26M |
| Stockholders Equity | 7.09B | 9.02B | 5.60B | 2.93B | 777.77M | 409.61M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.32B | 3.90B | 2.06B | 653.47M | 12.04M |
| Operating Cash Flow | 0.00 | 5.48B | 3.96B | 2.08B | 678.97M | 15.88M |
| Investing Cash Flow | 0.00 | -308.34M | -400.20M | -79.29M | -57.29M | -34.29M |
| Financing Cash Flow | 0.00 | -2.43B | -110.48M | 804.89M | -347.00K | 443.92M |
M&A Research Institute Holdings Inc. reported a challenging fiscal year ending September 2025, with a slight increase in net sales but significant declines in operating and ordinary profits, as well as profit attributable to owners of the parent. Despite these setbacks, the company has revised its year-end dividend per share from 0.00 yen to 5.00 yen, indicating a commitment to shareholder returns. The company is also forecasting a positive outlook for the next fiscal year with expected growth in net sales and profits, driven by strategic expansions and new inclusions in its operations.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1184.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has reported extraordinary losses in its non-consolidated financial results for the fiscal year ending September 2025, due to a provision for allowance for doubtful accounts and a loss on valuation of shares of its affiliate, Quants Consulting, Inc. Despite these accounting losses, the company emphasizes that there is no material impact on the affiliate’s operations and continues to prioritize strategic investments for future growth, maintaining a focus on enhancing corporate value and sustainable profit growth over the medium to long term.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1184.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has announced its decision to voluntarily adopt the International Financial Reporting Standards (IFRS) for its consolidated financial statements, replacing the current Japanese GAAP. This strategic move aims to enhance the international comparability of its financial information, potentially improving its global market positioning and offering greater transparency for stakeholders.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1184.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has announced its first-ever dividend distribution from retained earnings, marking a significant shift in its financial strategy. This decision reflects the company’s strengthened financial base and stable cash flow, aiming to enhance stock value and shareholder stability while balancing growth investments and shareholder returns.
The most recent analyst rating on (JP:9552) stock is a Hold with a Yen1184.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. announced a change in its executive team, appointing Hiroki Kagami as the new CFO, effective October 1, 2025. This change is part of the company’s strategy to accelerate growth and enhance governance, with former CFO Hikaru Ogino transitioning to lead the Internal Audit Office to bolster the company’s governance framework.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen1512.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has announced the cancellation of 5,211,458 treasury shares, which constitutes 8.79% of its total issued shares. This strategic move, scheduled for September 26, 2025, will reduce the company’s total issued shares to 54,101,335, potentially enhancing shareholder value and optimizing the company’s capital structure.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen1512.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has repurchased 1,267,500 of its own common shares for 1,652,415,800 yen through market purchases on the Tokyo Stock Exchange during July 2025. This repurchase is part of a broader initiative approved by the Board of Directors to buy back up to 7,500,000 shares, indicating a strategic move to consolidate ownership and potentially enhance shareholder value.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.